MRI‐based radiomics has been used to diagnose breast lesions; however, little research combining quantitative pharmacokinetic parameters of dynamic contrast‐enhanced MRI (DCE‐MRI) and diffusion kurtosis imaging (DKI) exists. Click to show full abstract
MRI‐based radiomics has been used to diagnose breast lesions; however, little research combining quantitative pharmacokinetic parameters of dynamic contrast‐enhanced MRI (DCE‐MRI) and diffusion kurtosis imaging (DKI) exists.
               
Click one of the above tabs to view related content.